COMPANY

ElmediX

Location: New York, NY · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Pancreatic Ductal Adenocarcinoma (mPDAC) Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Pancreatic Cancer Metastatic

Timeline

Oct 1, 2026 Trial start Phase 2/Phase 3: A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer source ↗
Jul 28, 2021 Trial start Not phased (device or behavioral study): Safety Study of Whole Body Hyperthermia for Advanced Cancer source ↗

Mar 31, 2030 (ESTIMATED) · Phase 2/Phase 3 · A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer · NCT07711067

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07711067	A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer	Phase 2/Phase 3	Not yet recruiting	Oct 1, 2026	Mar 31, 2030 (estimated)
NCT04467593	Safety Study of Whole Body Hyperthermia for Advanced Cancer	Not phased (device or behavioral study)	Completed	Jul 28, 2021	Dec 25, 2024 (actual)